These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23393216)

  • 1. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.
    Tsur A; Feldman BS; Feldhammer I; Hoshen MB; Leibowitz G; Balicer RD
    Diabetes Care; 2013 May; 36(5):1361-7. PubMed ID: 23393216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
    Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
    Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Lin SX; Berlin I; Younge R; Jin Z; Sibley CT; Schreiner P; Szklo M; Bertoni AG
    Diabetes Care; 2013 Feb; 36(2):342-7. PubMed ID: 23033247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression from newly acquired impaired fasting glusose to type 2 diabetes.
    Nichols GA; Hillier TA; Brown JB
    Diabetes Care; 2007 Feb; 30(2):228-33. PubMed ID: 17259486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.
    Wang L; Cui L; Wang Y; Vaidya A; Chen S; Zhang C; Zhu Y; Li D; Hu FB; Wu S; Gao X
    Int J Epidemiol; 2015 Apr; 44(2):689-99. PubMed ID: 26002923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and impaired fasting glycemia in a rural population of Bangladesh.
    Sayeed MA; Mahtab H; Akter Khanam P; Abdul Latif Z; Keramat Ali SM; Banu A; Ahren B; Azad Khan AK
    Diabetes Care; 2003 Apr; 26(4):1034-9. PubMed ID: 12663569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
    Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
    Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.
    Rasmussen SS; Glümer C; Sandbaek A; Lauritzen T; Borch-Johnsen K
    Diabetologia; 2008 Feb; 51(2):249-57. PubMed ID: 18060659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.
    Qian Y; Lin Y; Zhang T; Bai J; Chen F; Zhang Y; Luo S; Shen H
    BMC Public Health; 2010 Mar; 10():139. PubMed ID: 20233452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.
    Han SJ; Kim HJ; Kim DJ; Lee KW; Cho NH
    Diabetes Res Clin Pract; 2017 Jan; 123():173-180. PubMed ID: 28043048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men.
    Nakanishi N; Yoshida H; Matsuo Y; Suzuki K; Tatara K
    Diabetologia; 2002 Jan; 45(1):42-8. PubMed ID: 11845222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
    Liu J; Joshi D; Sempos CT
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fasting glucose and impaired glucose tolerance in rural population of Bangladesh.
    Rahim MA; Azad Khan AK; Nahar Q; Ali SM; Hussain A
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):47-51. PubMed ID: 21473200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
    Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.